SAN FRANCISCO, Oct. 17 – Tranzyme and the University of Utah Genome Center have collaborated to develop gene libraries, the organizations announced Wednesday.
Birmingham, Ala.-based Tranzyme will use its genomics platform to help build the libraries as it uses the joint project to advance its technologies, used for analysis of gene function, target validation, and assay development, according to the company.
Financial details of the agreement were not disclosed.
“This partnership provides a unique opportunity to combine our genome technology with Tranzyme's applied genomics capabilities,” Robert Weiss, co-director of the university’s Genome Center, said in a statement. “Our collaboration with Tranzyme allows us to evaluate the functional effects of genetic variations in a smooth continuum of biological assays ranging through in vitro , ex vivo , and in vivo model systems.”
The University of Utah Genome Center participated in the Human Genome Project. The center is currently involved in the Environmental Genome Project for the evaluation of sequence variation in environmental response genes as well as the mouse and rat genome projects.
In September, Tranzyme made a deal with Active Pass Pharmaceuticals of Vancouver to combine technologies in an effort to study gene expression and bolster their drug discovery programs.